Weight loss

AOD-9604

Name: AOD-9604: uses, evidence and safety
Creator: Cited Peptides Editorial

Fat loss. A fragment of growth hormone sold as a "fat burner".

By Cited Peptides Editorial Updated 2026-10-10 Medical review pending

This page has not yet been reviewed by a credentialed medical professional. It is educational and is not medical advice.

AOD-9604: key facts

Evidence level Animal studies only
Approved as a medicineNo
Randomized trials on PubMed0
Papers on PubMed22
Trials testing it (ClinicalTrials.gov)None found
In tested sportProhibited

In one sentence: AOD-9604 is not an approved medicine. Its strongest evidence is animal studies, with 0 randomized trials on PubMed that mention it.

What the evidence says

Little published human data and no randomized trials found on PubMed. Sold online as a research chemical without approval.

Key studies

Reviews Summaries of other studies.

Review2004 AOD-9604 Metabolic Curr Opin Investig Drugs PMID 15134286 → Review2026 Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance Sports Med PMID 41966639 → Review2026 Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions J Am Acad Orthop Surg Glob Res Rev PMID 41490200 → Review2012 Current updates in the medical management of obesity Recent Pat Endocr Metab Immune Drug Discov PMID 22435392 →

Other notable papers The most relevant other papers on PubMed.

Research Support, N.I.H., Extramural, Validation Study2015 Detection and in vitro metabolism of AOD9604 Drug Test Anal PMID 25208511 → 2015 Effect of Intra-articular Injection of AOD9604 with or without Hyaluronic Acid in Rabbit Osteoarthritis Model Ann Clin Lab Sci PMID 26275694 → Comparative Study, Research Support, Non-U.S. Gov't2001 Increase of fat oxidation and weight loss in obese mice caused by chronic treatment with human growth hormone or a modified C-terminal fragment Int J Obes Relat Metab Disord PMID 11673763 → Research Support, Non-U.S. Gov't2001 The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice Endocrinology PMID 11713213 →

See its full evidence profile and newest papers →

Clinical trials

No registered trials list AOD-9604 as a treatment.

That usually means it hasn't been properly tested in people.

Search all trials live →

Where it fits

GoalPeptides for weight loss ComparisonSemaglutide vs AOD-9604 ComparisonTirzepatide vs AOD-9604 ComparisonRetatrutide vs AOD-9604 ComparisonLiraglutide vs AOD-9604

Common questions

Is AOD-9604 approved?

No. AOD-9604 is not an approved medicine in the US or Canada.

Has AOD-9604 been tested in people?

No randomized trials of AOD-9604 are listed on PubMed. Little published human data and no randomized trials found on PubMed. Sold online as a research chemical without approval.

Is AOD-9604 allowed in sport?

No. It is prohibited by the World Anti-Doping Agency.

This is a short, data-driven profile. Study and trial lists come from PubMed and ClinicalTrials.gov and are refreshed periodically. "What people use it for" describes common claims, not recommendations. Educational only, not medical advice.